Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
•
Behavioral Neurology & Neuropsychiatry
How do you manage the manifestations of Creutzfeldt-Jakob disease?
Any preferred agents to use for Seizures and myoclonus?
Related Questions
What considerations do you take regarding using valproic acid in men who are hoping to conceive with a partner?
How do you counsel eligible patients on how to decide between lecanemab vs donanemab?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
What are the best practices for centers interested in providing anti-amyloid therapies for early Alzheimer's to ensure treatment delivery success?
When do you evaluate patients with Parkinson's disease and cognitive decline for concurrent Alzheimer's disease?
Besides patient preference, what factors guide your decision to treat SeLECTs patients with antiseizure medications?
How do you approach an isolated increased protein levels in the CSF in patients with cognitive decline?
Does valproic acid or lithium use in the egg donor pose a risk to the fetus in a surrogate pregnancy?
What is your approach to patients who develop ARIA-E or ARIA-H during treatment with anti-amyloid therapies?
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
